Safer and newer antimicrobial drugs for leprosy – time to test monthly ROM in an adequately powered randomised trial?
Diana NJ Lockwood 
;
Gerson O Penna ;
Saba Lambert ;
Vivek Vasudev Pai ;
Stephen L Walker ;
(2022)
Safer and newer antimicrobial drugs for leprosy – time to test monthly ROM in an adequately powered randomised trial?
Leprosy Review, 93 (2).
pp. 96-101.
ISSN 0305-7518
DOI: 10.47276/lr.93.2.96
;
Gerson O Penna ;
Saba Lambert ;
Vivek Vasudev Pai ;
Stephen L Walker ;
(2022)
Safer and newer antimicrobial drugs for leprosy – time to test monthly ROM in an adequately powered randomised trial?
Leprosy Review, 93 (2).
pp. 96-101.
ISSN 0305-7518
DOI: 10.47276/lr.93.2.96
In the last decade many leprologists around the world have been advocating the development and testing of new antimicrobial treatments for leprosy but limited new clinical data have emerged. Global guidelines have been published in which the World Health Organization (WHO) now recommends rifampicin, dapsone and clofazimine for all individuals diagnosed with leprosy.
-
picture_as_pdf - Lockwood_etal_2022_Safer-and-newer-antimicrobial-drugs.pdf
-
subject - Published Version
-
- Available under Creative Commons: 4.0
Downloads